[Federal Register Volume 65, Number 174 (Thursday, September 7, 2000)]
[Notices]
[Pages 54278-54279]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-22902]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Workshop in Vaccine Communication

    The National Vaccine Program Office (NVPO), of the Centers for 
Disease Control and Prevention (CDC), announces the following meeting.
    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.
    Name: Workshop on Vaccine Communication.
    Times and Dates: 8:30 a.m.--6 p.m., October 5, 2000. 8:30 a.m.--2 
p.m., October 6, 2000.
    Place: Key Bridge Marriott Hotel, Arlington, Virginia.
    Status: Open to the public, limited only by the space available. 
The meeting

[[Page 54279]]

room accommodates approximately 150 people.
    Purpose: The National Vaccine Advisory Committee, the Inter-Agency 
Vaccine Communications Group and the National Vaccine Program Office 
will sponsor a Workshop on Vaccine Communication to provide a forum for 
identifying and discussing more effective approaches to vaccine benefit 
and risk communication.
    This Workshop should be of interest to people working in the 
vaccine and immunization arena including health communication and 
public affairs specialists, public and private sector health care 
providers, parent and consumer groups, vaccine manufacturers, and 
immunization program managers and directors.
    Matters to be Discussed: The Workshop will focus on (1) identifying 
key issues, forces and trends that are influencing and shaping 
perceptions about vaccines; (2) determining how to establish more 
meaningful discussions regarding issues of concern; (3) defining 
options for establishing more effective mechanisms for communicating 
vaccine benefits and risks; and (4) examining and discussing the 
effectiveness, purpose, methods, and timing of current vaccine 
communications.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Lena Kombo, NVPO, CDC, 1600 
Clifton Road, NE, M/S D66, Atlanta, Georgia 30333, telephone 404/687-
6672. You may also visit the NVPO website for additional information: 
www.cdc.gov/od/nvpo/calendar. The Director, Management Analysis and 
Services Office, has been delegated the authority to sign Federal 
Register Notices pertaining to announcements of meetings and other 
committee management activities, for both the Centers for Disease 
Control and Prevention and the Agency for Toxic Substances and Disease 
Registry.

    Dated: August 31, 2000.
John Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 00-22902 Filed 9-6-00; 8:45 am]
BILLING CODE 4163-18-P